Based on the transcriptome of survival‐related SLC family genes, we identified novel molecular subtypes (SLC‐S1 and SLC‐S2) of gastric cancer that remarkedly correlated with different clinical outcomes, TME landscape and biological pathways. The gene discussed is CCL21; the disease is gastric cancer.